Keywords: ph, iii, silenor, data, confirms, positive, package

Ph III Silenor data confirms positive data package

Article | 19 May 2008

Print This

The USA's Somaxon Pharmaceuticals has reported strong data from three Phase III clinical trials of Silenor (doxepin HCl) for insomnia ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in